Download PDF
Viszeralchirurgie 2002; 37(3): 250-258
DOI: 10.1055/s-2002-32389
Originalarbeit
© Georg Thieme Verlag Stuttgart · New York

Die Bedeutung der Bluttransfusion in
der kolorektalen Tumorchirurgie

Significance of blood transfusion in colorectal cancerK.  Pfister1 , B.  Dietl2 , A.  Fürst1 , G.  Multhoff3 , K.-W.  Jauch1
  • 1Chirurgische Klinik und Poliklinik der Universität Regensburg
  • 2Strahlentherapie der Universität Regensburg
  • 3Hämatologie und internistische Onkologie der Universität Regensburg, AG Natürliche Killerzellen
Further Information

Publication History

Publication Date:
20 June 2002 (online)

    Permissions and Reprints

Zusammenfassung

Mehr als die Hälfte aller Patienten mit kolorektalem Karzinom wird durch die tumorinduzierte Anämie und den perioperativen Blutverlust transfusionsbedürftig. Obwohl bisher der kausale Mechanismus nicht bekannt ist, gilt die fremdblutassoziierte Immunsuppression experimentell und klinisch als bewiesen. Eine Erhöhung der postoperativen Infektionsrate durch die Transfusion wird übereinstimmend bejaht, die Beeinträchtigung der Tumorprognose sowie eine erhöhte Rezidivrate jedoch kontrovers diskutiert. In dieser Übersichtsarbeit wurde die Literatur zum gesamten Themenkomplex zusammengetragen und analysiert. Die überwiegend retrospektiven Daten lassen derzeit keine definitive Beurteilung der klinischen Auswirkungen des negativen Transfusionseffektes zu. Dennoch sollte der Risikofaktor Bluttransfusion möglichst vermieden werden.

Abstract

More than half of all patients with colorectal cancer need blood transfusion because of tumor induced anemia or perioperative blood loss. Transfusion associated immunosuppression is a well known phenomenon although underlying mechanism is still not understood. Whereas in most studies concerning postoperative infection rate allogeneic blood transfusion had been an independent risk factor, controversial data have been published regarding the influence on colorectal cancer prognosis and tumor recurrence. The review analyzed the literature currently available. Clinical consequences of mainly retrospective surveys remain unclear. Therefore we suggest to avoid homologous blood transfusion wherever possible.

Schlüsselwörter

Anämie - Bluttransfusion - kolorektales Karzinom - postoperative Infektionsrate - Tumorprognose

Key words

Tumor induced anemia - Blood transfusion - Colorectal cancer - Postoperative infection rate - Cancer prognosis

Literatur

  • 1 Hansen E, Taeger K, Hofstädter F. Die Retransfusion von Wundblut bei Tumorpatienten.  Dtsch Ärzteblatt. 1999;  41 B2097-2102
    PubMedGoogle Scholar
  • 2 Messmer K. Roundtable of Experts in Surgery Blood Management-Consensus Statement.  Infusionsther Transfusionmed. 1996;  23 143-146
    PubMedGoogle Scholar
  • 3 Kettelhack C, Hoenes C, Messinger D, Schlag P M. Randomized multicentre trial of the influence of recombinant human erythropoietin on intraoperative and postoperative transfusion need in anaemic patients undergoing right hemicolectomy for carcinoma.  Br J Surg. 1998;  85 63-67
    CrossrefPubMedGoogle Scholar
  • 4 Geissmann D, Laffer U, Maibach R, Metzger U. SAKK . Transfusionsverhalten bei kurativ operierten Patienten mit kolorektalen Karzinomen.  Zentralbl Chir. 2000;  125 847-851
    Article in Thieme ConnectPubMedGoogle Scholar
  • 5 Harder F, Laffer U, Berres M, Jäggi P, Metzger U. SAKK . Nach kurativer Resektion colorectaler Carcinome wirkt die portale Chemotherapie vor allem beim nicht-transfundierten Patienten.  Chirurg. 1990;  61 280-285
    PubMedGoogle Scholar
  • 6 Swiss Group for Clinical Cancer Research (SAKK) . Association between blood transfusion and survival in a randomised multicentre trial of perioperative adjuvant portal chemotherapy in patients with colorectal cancer.  Eur J Surg. 1997;  163 693-701
    PubMedGoogle Scholar
  • 7 Nicholls M D, Whyte G. Red cell, plasma and albumin transfusion decision triggers.  Anaesth Intens Care. 1993;  21 156-162
    PubMedGoogle Scholar
  • 8 Hallissey M T, Crowson M C, Kiff R S, Kingston R D, Fielding J W. Blood transfusion: an overused resource in colorectal cancer surgery.  Ann R Coll Surg Engl. 1992;  74 59-62
    PubMedGoogle Scholar
  • 9 American College of Physicians . Practice strategies for elective red blood cell transfusion.  Ann Intern Med. 1991;  116 403-406
    PubMedGoogle Scholar
  • 10 Standards for Blood Banks and Transfusion Services . Prepared by Committee on Standards.  American Association of Blood Banks. 1993;  15 35-38
    PubMedGoogle Scholar
  • 11 Sirchia G, Giovanetti A M. et al .Safe and good use of blood in surgery (SANGUIS). Use of blood products and artificial colloids in 43 European hospitals. Luxemburg: European Commission 1994
    Google Scholar
  • 12 Houston F, Foster J B, Chong A. et al . Transmissioin of BSE by blood transfusion in sheep.  Lancet. 2000;  356 999-1000
    CrossrefPubMedGoogle Scholar
  • 13 Dodd R Y. Adverse consequences of blood transfusion: quantitative risk estimates. Nance ST ed Blood supply: risks, perceptions and prospects for the future. Bethesda: American Association of Blood Banks 1994: 1-24
    Google Scholar
  • 14 Taleghani M, Reith H B, Wiebecke D, Thiede A. Hämotherapie in der operativen Medizin.  Zentralbl Chir. 1999;  4 W27-41
    PubMedGoogle Scholar
  • 15 Opelz G, Sengar D PS, Mickey M R, Terasaki P I. Effect of blood transfusions on subsequent kidney transplants.  Transplant Proc. 1973;  5 253-259
    PubMedGoogle Scholar
  • 16 Opelz G, Terasaki P I. Improvement of kidney-graft survival with increased numbers of transfusions.  N Engl J Med. 1978;  299 799-803
    PubMedGoogle Scholar
  • 17 Heiss M M, Delanoff C. Immunmodulatorische Wirkung der Bluttransfusion und Einfluss auf Infektionsrate und Tumorrezidiv.  Infusionsther Transfusionmed. 1997;  24 20-31
    PubMedGoogle Scholar
  • 18 Houbiers J G, van de Velde C J, van de Watering L M, Hermans J, Schreuder S, Bijnen A B, Pahlplatz P, Schattenkerk M E, Wobbes T, de Vries J E, Klementschitsch P, van de Maas A H, Brand A. Transfusion of red cells in associated with increased incidence of bacterial infection after colorectal surgery: a prospective study.  Transfusion. 1997;  37 126-134
    CrossrefPubMedGoogle Scholar
  • 19 Schricker K T, Hermanek P, Guggenmoos-Holzmann I, Neidhardt B, Resch T, Freudenberger K. Verschlechterung des Überlebens bei kolorektalem Karzinom. Überraschende Ergebnisse einer Multivarianzanalyse.  Beitr Infusionsther. 1990;  26 307-312
    PubMedGoogle Scholar
  • 20 Marsh J, Donnan P T, Hamer-Hodges D W. Association between transfusion with plasma and the recurrence of colorectal carcinoma.  Br J Surg. 1990;  77 623-626
    PubMedGoogle Scholar
  • 21 Blajchman M A, Bordin J O. Mechanisms of transfusion-associated immunosuppression.  Curr Opin Hematol. 1994;  1 457-461
    PubMedGoogle Scholar
  • 22 Waymack J P, Alexander J W. Blood transfusion as an immunomodulator: a review.  Comp Immunol Microbiol Infect Dis. 1986;  9 177-183
    PubMedGoogle Scholar
  • 23 Blumberg N, Heal J M. Transfusion and recipient immune function.  Arch Pathol Lab Med. 1989;  113 246-253
    PubMedGoogle Scholar
  • 24 Roth J A, Golub S H, Grimm E A, Eilber F R, Morton D L. Effects of operation on immune response in cancer patients: sequential evaluation of in vitro lymphocyte function.  Surgery. 1976;  79 46-51
    PubMedGoogle Scholar
  • 25 Hunt P S, Trotter S. Lymphocyte response after surgery and blood transfusion.  J Surg Res. 1976;  21 57-64
    CrossrefPubMedGoogle Scholar
  • 26 Peller S, Sayfan J, Levy Y, Oland J, Yona R, Kaufman S, Orda R. Immunological profile changes following perioperative autologous vs. homologous blood transfusion in oncologic patients.  J Surg Oncol. 1994;  56 98-101
    PubMedGoogle Scholar
  • 27 Brivio F, Lissoni P, Redaelli R, Maggioni A, Rovelli F, Rescaldani R, Borin F, Erba L, Alderi G. Influence of blood transfusions on surgery-induced immune changes in colorectal carcinoma.  Miner Chir. 1993;  48 331-335
    PubMedGoogle Scholar
  • 28 Tartter P I, Steinberg B, Barron D, Martinelli G. Transfusion History, T Cell subsets and Natural killer cytotoxicity in Patients with colorectal cancer.  Vox Sang. 1989;  56 80-84
    PubMedGoogle Scholar
  • 29 Jensen L S, Andersen A J, Christiansen P M. et al . Post-operative infection and natural killer cell function following blood transfusion in patients undergoing elective colorectal surgery.  Br J Surg. 1992;  79 513-516
    PubMedGoogle Scholar
  • 30 Ishijima N, Suzuki H. Blood transfusion and postoperative serum interleukin-6 levels in colorectal cancer patients.  Hepato-Gastroenterol. 1998;  45 1011-1013
    PubMedGoogle Scholar
  • 31 Ziv Y, Shohat B, Gelerenter I, Wolloch Y. The influence of perioperative transfusions on the immunological profile of patients with colorectal adenocarcinoma.  Panminerva Med. 1992;  34 4-12
    PubMedGoogle Scholar
  • 32 Mathiesen O, Lund L, Brodthagen U, Gandrup P, Grunnet N, Balslev I, Jersild C. The effect of previous blood transfusion on lymphocyte subsets and natural killer cell function in patients with colorectal cancer.  Vox Sang. 1994;  67 36-41
    PubMedGoogle Scholar
  • 33 Gantt C L. Red blood cells for cancer patients (letter).  Lancet. 1981;  ii 363
    PubMedGoogle Scholar
  • 34 van de Watering L MG. et al . Beneficial effects of leukocyte depletion of transfused blood on postoperative complications in patients undergoing cardiac surgery.  Circulation. 1998;  97 562-568
    PubMedGoogle Scholar
  • 35 Tartter P I, Quintero S, Barron D M. Perioperative Blood transfusion associated with infectious complications after colorectal cancer operations.  Am J Surg. 1986;  152 479-482
    CrossrefPubMedGoogle Scholar
  • 36 Duffy G, Neal K R. Differences in post-operative infection rates between patients receiving autologous and allogeneic blood transfusion - a meta-analysis of published randomized and nonrandomized studies.  Transfus Med. 1996;  6 325-328
    PubMedGoogle Scholar
  • 37 Tartter P I. Blood transfusion and infectious complications following colorectal cancer surgery.  Br J Surg. 1988;  75 789-792
    PubMedGoogle Scholar
  • 38 Chiarugi M, Buccianti P, di Sarli M, Galatioto C, Goletti O, Cavina E. Association between perioperative blood transfusion and dehiscence of anastomosis after rectal resection for cancer.  Acta Chir Belg. 1996;  96 108-111
    PubMedGoogle Scholar
  • 39 Ford C D, VanMoorleghem G, Menlove R L. Blood transfusions and postoperative wound infection.  Surgery. 1993;  113 603-607
    PubMedGoogle Scholar
  • 40 Vignali A, Braga M, Gianotti L, Radaelli G, Gentilini O, Russo A, di Carlo V. A single unit of transfused allogeneic blood increases postoperative infections.  Vox Sang. 1996;  71 170-175
    CrossrefPubMedGoogle Scholar
  • 41 Jaberth A V, Lee E T, Hersch E M, McBride C M. Effects of surgery, anesthesia and intraoperative blood loss on immunocompetence.  J Surg Res. 1973;  15 399-403
    CrossrefPubMedGoogle Scholar
  • 42 Heald R J, Ryall R D. Recurrence and survival after total mesorectal excision after rectal cancer.  Lancet. 1986;  2 1479-1482
    PubMedGoogle Scholar
  • 43 Vamvakas E C, Carven J H. Transfusion of white-cell containing allogeneic blood components and postoperative wound infection: effect of confounding factors.  Transfusion Med. 1998;  8 29-36
    PubMedGoogle Scholar
  • 44 Vamvakas E C, Carven J H, Hibberd P L. Blood Transfusion and infection after colorectal cancer surgery.  Transfusion. 1996;  36 1000-1008
    CrossrefPubMedGoogle Scholar
  • 45 Jensen L S, Hokland M, Nielsen H J. A randomized controlled study of the effect of bedside leucocyte depletion on the immunosuppressive effect of whole blood transfusion in patients undergoing elective colorectal surgery.  Br J Surg. 1996;  83 973-977
    PubMedGoogle Scholar
  • 46 Jensen L S, Kissmeyer-Nielsen P, Wolff B, Qvist N. Randomised comparison of leucocyte-depleted versus buffy-coat-poor blood transfusion and complications after colorectal surgery.  Lancet. 1996;  348 841-845
    CrossrefPubMedGoogle Scholar
  • 47 Heiss M M, Mempel W, Jauch K W, Delanoff C, Mayer G, Mempel M, Eissner H J, Schildberg F W. Beneficial effect of autologous blood transfusion on infectious complications after colorectal cancer surgery.  Lancet. 1993;  342 1328-1333
    CrossrefPubMedGoogle Scholar
  • 48 Heiss M M, Mempel W, Delanoff C, Mempel M, Jauch K W, Schildberg F W. Klinische Auswirkungen der mit einer Bluttransfusion assoziierten Immunmodulation auf das Ergebnis der Tumoroperation.  Infusionsther Transfusionsmed. 1993;  20 (Suppl 2) 25-29
    PubMedGoogle Scholar
  • 49 Jensen L S, Heiss M M, Mempel W, Jauch K W, Schildberg F W, Ross W B, Houbiers J GA, van de Watering L MG, Verwey P JM, van de Velde C JH, Brand A. Leucocyte-depleted or buffy-coat-depleted blood in surgery for colorectal cancer.  Lancet. 1994;  344 1429-1431
    CrossrefPubMedGoogle Scholar
  • 50 Houbiers J G, Brand A, van de Watering L M, Hermans J, Verwey P J, Bijnen A B, Pahlplatz P, Eeftinck S chattenkerk, Wobbes T, de Vries J E. Randomised controlled trial comparing transfusion of leucocyte-depleted or buffy-coat-depleted blood in surgery for colorectal cancer.  Lancet. 1994;  344 573-578
    CrossrefPubMedGoogle Scholar
  • 51 Busch O RC, Hop W CI, van Papendrecht M AV, Marquet R L, Jeekel J. Blood transfusions and prognosis in colorectal cancer.  N Engl J Med. 1993;  328 1372-1376
    CrossrefPubMedGoogle Scholar
  • 52 Vignali A, Braga M, Dionigi P, Radaelli G, Gentilini O, Bellini A, Jemos V, di Carlo V. Impact of a programme of autologous blood donation on the incidence of infection in patients with colorectal cancer.  Eur J Surg. 1995;  161 487-492
    PubMedGoogle Scholar
  • 53 Parrot N R, Lennard T W, Taylor R M, Proud G, Shenton B K, Johnston I D. Effects of perioperative blood transfusion on recurrence of colorectal cancer.  Br J Surg. 1986;  73 970-973
    PubMedGoogle Scholar
  • 54 Burrows L, Tartter P, Aufses A. Increased recurrence rates in perioperatively transfused colorectal malignancy patients.  Cancer Detect Prev. 1987;  10 361-369
    PubMedGoogle Scholar
  • 55 Creasy T S, Veitch P S, Bell P R. A relationship between perioperative blood transfusion and recurrence of carcinoma of the sigmoid colon following potentially curative surgery.  Ann R Coll Surg Engl. 1987;  69 100-103
    PubMedGoogle Scholar
  • 56 Beynon J, Davies P W, Billings P J. et al . Perioperative blood transfusion increases the risk of recurrence in colorectal cancer.  Dis Colon Rectum. 1989;  29 975-979
    PubMedGoogle Scholar
  • 57 Mecklin J P, Jarvinen J H, Ovaska J T. Blood transfusion and prognosis in colorectal carcinoma.  Scand J Gastroenterol. 1989;  24 33-39
    PubMedGoogle Scholar
  • 58 Wobbes T, Joosen K H, Kuypers H H, Beerthuizen G I, Theeuwes A G. The effect of packed cells and whole blood transfusions on survival after curative resection for colorectal carcinoma.  Dis Colon Rectum. 1989;  32 743-748
    PubMedGoogle Scholar
  • 59 Blumberg N, Chuang-Stein C, Heal J M. The relation-ship of blood transfusion, tumor staging, and cancer recurrence.  Transfusion. 1990;  30 291-294
    CrossrefPubMedGoogle Scholar
  • 60 Kijems E, Schydlowski P, Sondergaard J O. The influence of blood transfusions upon the recurrence rate of colorectal cancer.  Rev Med Chir Soc Med Nat Iasi. 1991;  95 265-268
    PubMedGoogle Scholar
  • 61 Tang R, Wang J Y, Chang-Chien C R, Chen J S, Lin S E, Hong A F. The asssociation between perioperative blood transfusion and survival of patients with colorectal cancer.  Cancer. 1993;  72 341-348
    PubMedGoogle Scholar
  • 62 Frankish P D, McNee R K, Alley P G, Woodfield D G. Relation between cancer of the colon and blood transfusion.  BMJ. 1985;  290 1827
    PubMedGoogle Scholar
  • 63 Francis D M, Judson R T. Blood transfusion and recurrence of cancer of the colon.  Br J Surg. 1987;  74 26-30
    PubMedGoogle Scholar
  • 64 van Lawick X, Pabst W P, Lagenhorst B L, Mulder P G, Marquet R L, Jeekel J. Effect of perioperative blood loss and perioperative blood transfusions on colorectal cancer survival.  Eur J Cancer Clin Oncol. 1988;  24 741-747
    CrossrefPubMedGoogle Scholar
  • 65 Cheslyn-Curtiss S, Fielding L P, Hittinger R, Fry J S, Phillips R K. Large bowel cancer: the effect of perioperative blood transfusion on outcome.  Ann R Coll Surg Engl. 1990;  72 53-59
    PubMedGoogle Scholar
  • 66 Edna T H, Bjerkeset T. Perioperative blood transfusions reduce long-term survival following surgery for colorectal cancer.  Dis Colon Rectum. 1998;  41 451-459
    PubMedGoogle Scholar
  • 67 The Swiss Group for Clinical Cancer Research . Association between blood transfusion and survival in a randomised multicentre trial of perioperative adjuvant portal chemotherapy in patients with colorectal cancer.  Eur J Surg. 1997;  163 693-701
    PubMedGoogle Scholar
  • 68 Hermanek P. Beeinflussen perioperative Bluttransfusionen die Prognose von Patienten mit kolorektalem Karzinom?.  Strahlenther Onkologie. 1996;  172 283-284
    PubMedGoogle Scholar
  • 69 Blumberg N, Heal J M. Perioperative blood transfusion and colorectal cancer recurrence.  Transfusion. 1994;  34 450-452
    CrossrefPubMedGoogle Scholar
  • 70 Leite J F, Granjo M E, Martins M I, Reis R C, Monteiro J C, Castro-Sousa F. Effect of perioperative blood transfusions on survival of patients after radical surgery for colorectal cancer.  Int J Colorectal Dis. 1993;  8 129-133
    CrossrefPubMedGoogle Scholar
  • 71 Jahnson S, Andersson M. Adverse effects of perioperative blood transfusion in patients with colorectal cancer.  Eur J Surg. 1992;  158 419-425
    PubMedGoogle Scholar
  • 72 Faenza A, Cusolo A, Selleri S, Lucarell S, Farneti P A, Gozzetti G. Correlation between plasma or blood transfusion and survival after curative surgery for colorectal cancer.  Int Surg. 1992;  77 264-269
    PubMedGoogle Scholar
  • 73 Tartter P I. The association of perioperative blood transfusion with colorectal cancer recurrence.  Ann Surg. 1992;  216 633-638
    PubMedGoogle Scholar
  • 74 Zimmermann T, Dobroschke J, Borowek U, Padberg W. Der Einfluss der perioperativen Fremdblutgabe auf die Prognose des kolorektalen Karzinoms.  Zentralbl Chir. 1991;  116 1125-1138
    PubMedGoogle Scholar
  • 75 Weiden P L. Do perioperative blood transfusions increase the risk of cancer recurrence?.  Eur J Cancer. 1990;  26 987-989
    PubMedGoogle Scholar
  • 76 Liewald F, Wirsching R P, Zuelke C, Demmel N, Mempel W. Influence of blood transfusions on tumor recurrence and survival rate in colorectal carcinoma.  Eur J Cancer. 1990;  26 327-335
    PubMedGoogle Scholar
  • 77 Freiman J A, Chalmers T C, Smith H, Kuebler R R. The importance of beta, the type II error and sample size in the design and interpretation of randomized controlled trial.  N Engl J Med. 1978;  299 690-694
    PubMedGoogle Scholar
  • 78 Chung M, Steinmetz O K, Gordon P H. Perioperative blood transfusion and outcome after resection for colorectal carcinoma.  Br J Surg. 1993;  80 427-432
    PubMedGoogle Scholar
  • 79 Vamvakas E, Moore S B. Perioperative blood transfusion and colorectal cancer recurrence: a qualitative statistical overview and meta-analysis.  Transfusion. 1993;  33 754-765
    CrossrefPubMedGoogle Scholar
  • 80 Vamvakas E C. Perioperative blood transfusion und cancer recurrence: meta-analysis for explanation.  Transfusion. 1995;  35 760-768
    CrossrefPubMedGoogle Scholar
  • 81 Amato A C, Pescatori M. Effect of perioperative blood transfusions on recurrence of colorectal cancer: Meta-analysis stratified on risk factors.  Dis Colon Rectum. 1998;  41 570-585
    CrossrefPubMedGoogle Scholar
  • 82 Vamvakas E C. Transfusion-associated cancer recurrence and postoperative infection: meta-analysis of randomized, controlled clinical trials.  Transfusion. 1996;  36 175-186
    CrossrefPubMedGoogle Scholar
  • 83 Busch O RC, Hop W CJ, Marquet R L, Jeekel J. Prognostic impact of blood transfusions on disease-free survival in colorectal carcinoma.  Scand J Gastroenterol. 1993;  (Suppl) 21-23
    PubMedGoogle Scholar
  • 84 Busch O RC, Hop W CJ, Marquet R L, Jeekel J. The effect of blood transfusions on survival after surgery for colorectal cancer.  Eur J Cancer. 1995;  31A 1226-1228
    PubMedGoogle Scholar
  • 85 Molland G, Dent O F, Chapuis P H, Bokey E L, Nicholls M, Newland R C. Transfusion does not influence patient survival after resection of colorectal cancer.  Aust Nz J Surg. 1995;  65 592-595
    PubMedGoogle Scholar
  • 86 Donohue J H, Williams S, Cha S, Windschitl H E, Witzig T E, Nelson H, Fitzgibbons R J, Wieand H S, Moertel C G. Peroperative blood transfusions do not affect disease recurrence of patients undergoing curative resection of colorectal carcinoma: a Mayo/North Central Cancer Treatment Group study.  J Clin Oncol. 1995;  13 1671-1678
    PubMedGoogle Scholar
  • 87 Busch O R, Hop W C, Marquet R L, Jeekel J. Blood transfusions and local tumor recurrence in colorectal cancer. Evidence of a noncausal relationship.  Ann Surg. 1994;  220 791-797
    PubMedGoogle Scholar
  • 88 Steup W H, Hojo K, Moriya Y, Sugihara K, Mizuno S, Hermans J, van de Velde C J. An analysis on the effect of blood transfusion on recurrence and survival in patients undergoing extended lymphadenectomy for colorectal cancer.  Hepato-Gastroenterol. 1994;  41 253-259
    PubMedGoogle Scholar
  • 89 Garau I, Benito E, Bosch F X, Bargay J, Obrador A, Santamaria J, Antich J L, Besalduch J, Rifa J, Teuchmann S. Blood transfusion has no effect on colorectal cancer survival. A population-based study.  Eur J Cancer. 1994;  30A 759-764
    PubMedGoogle Scholar
  • 90 Sibbering D M, Locker A P, Hardcactle J D, Armitage N C. Blood transfusion and survival in colorectal cancer.  Dis Colon Rectum. 1994;  37 358-364
    PubMedGoogle Scholar
  • 91 Ford C D, Gillette J W, Handrahan D L, Koehler C S. Transfusion and second malignancy.  Transfusion. 1994;  34 63-65
    CrossrefPubMedGoogle Scholar
  • 92 Sene A, Jeacock J, Robinson C, Walsh S, Kingston R D. Blood transfusion does not have an adverse effect on survival after operation for colorectal cancer.  Ann R Coll Surg Engl. 1993;  75 261-266
    PubMedGoogle Scholar
  • 93 Modin S, Karlsson G, Wahlby L. Blood transfusion and recurrence of colorectal cancer.  Eur J Surg. 1992;  158 371-375
    PubMedGoogle Scholar
  • 94 Bentzen S M, Balslev I, Pedersen M, Teglbjaerg P S, Hanberg-Sorensen F, Bone J, Jacobsen N O, Sell A, Overgaard J, Bertelsen K. et al . Blood transfusion and prognosis in Dukes' B and C colorectal cancer.  Eur J Cancer. 1990;  26 457-463
    PubMedGoogle Scholar
  • 95 Jakobsen E B, Eickhoff J H, Andersen J, Lundvall L, Stenderup J K. Perioperative blood transfusion and recurrence and death after resection for cancer of the colon and rectum.  Scand J Gastroenterol. 1990;  25 435-442
    PubMedGoogle Scholar
  • 96 McAlister F A, Clark H D, Wells P S, Laupacis A. Perioperative allogeneic blood transfusion does not cause adverse sequelae in patients with cancer: A meta-analysis of unconfounded studies.  Br J Surg. 1998;  85 171-178
    CrossrefPubMedGoogle Scholar
  • 97 Busch O RC, Marquet R L, Hop W CI, Jeekel J. Colorectal cancer recurrence and perioperative blood transfusions: A critical reappraisal.  Sem Surg Oncol. 1994;  10 195-199
    PubMedGoogle Scholar
  • 98 Heiss M M, Mempel W, Delanoff C, Jauch K W, Gabka C, Mempel M, Dieterich H J, Eissner H J, Schildberg F W. Blood transfusion-modulated tumor recurrence: first results of a randomized study of autologous versus allogeneic blood transfusion in colorectal cancer surgery.  J Clin Oncol. 1994;  12 1859-1867
    PubMedGoogle Scholar
  • 99 Francis D MA. Relationship between blood transfusion and tumour behaviour.  Br J Surg. 1991;  78 1420-1428
    PubMedGoogle Scholar
  • 100 Nielsen H J. Detrimental effects of perioperative blood transfusion.  Br J Surg. 1995;  82 582-587
    PubMedGoogle Scholar
  • 101 Singh S K, Marquet R L, de Bruin R WF, Westbroek D L, Jeekel J. Promotion of tumour growth by blood transfusions.  Transplant Proc. 1987;  19 1473-1474
    PubMedGoogle Scholar
  • 102 Tartter P I, Francis D M. Blood transfusion and tumor growth.  Transplant Proc. 1988;  20 1108-1111
    PubMedGoogle Scholar
  • 103 Hebert P C. et al . A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care.  NEJM. 1999;  340 409-417
    PubMedGoogle Scholar
  • 104 Hogue C W, Goodnough L T, Monk T G. Perioperative myocardial ischemic episodes are related to hematocrit level in patients undergoing radical prostatectomy.  Transfusion. 1998;  38 924-993
    CrossrefPubMedGoogle Scholar
  • 105 Marquet R L, de Bruin R W, Dallinga R, Singh S K, Jeekel J. Modulation of tumor growth by allogenic blood transfusion.  J Cancer Res Clin Oncol. 1986;  11 50-53
    PubMedGoogle Scholar
  • 106 Singh S K, Marquet R L, de Bruin R W, Hop W C, Westerbroek D L, Jeekel J. Consequences of blood loss on growth of artificial metastases.  Br J Surg. 1988;  75 377-379
    PubMedGoogle Scholar
  • 107 Francis D M, Shenton B K, Proud G, Taylor R M. Tumor growth and blood transfusion.  J Exp Clin Cancer Res. 1982;  1 121-126
    PubMedGoogle Scholar
  • 108 Eggermont A M, Stellar E P, Sugarbaker P H. Laparotomy enhances intraperitoneal tumor growth and abrogates the antitumor effects of interleukin-2 and lymphokine-activated killer cells.  Surgery. 1987;  102 71-78
    PubMedGoogle Scholar
  • 109 Bordin J O, Bardossy L, Blajchman M A. Growth enhancement of established tumors by allogeneic blood transfusion in experimental animals and its amelioration by leucodepletion.  Blood. 1994;  84 344-348
    PubMedGoogle Scholar
  • 110 de Canniere L, Rosiere A, Michel L A. Synchronous abdominoperineal resection without transfusion.  Br J Surg. 1993;  80 1194-1195
    PubMedGoogle Scholar
  • 111 Taleghani M, Grossmann R, Reith H B, Wiebecke D, Thiede A. Fremdblutsparende Maßnahmen in der operativen Medizin.  Zentralbl Chir. 2000;  125 111-122
    PubMedGoogle Scholar
  • 112 Leben J, Schregel W. Ist perioperative Wärmung wirtschaftlich vertretbar oder ist Nicht-Wärmung heute noch wirtschaftlich vertretbar?.  J Anästh Intensiv. 2001;  3 171-173
    PubMedGoogle Scholar
  • 113 Siebeck M, Schorr M, Heckl U. et al .Effekt von Aprotinin auf Blutverlust und Transfusion beim Rektumresektionen. Postersitzung Viszeralchirurgie und Forschung. Wiss. Referate 77. Tagung Ver. Bayer. Chir 2000
    Google Scholar
  • 114 Lentschener C, Benhamou D, Mercier F J. et al . Aprotinin reduces blood loss in patients undergoing elective liver resection.  Anest Analg. 1997;  84 (4) 875-881
    PubMedGoogle Scholar
  • 115 Porte R J, Molenaar I Q, Begliomini B. et al . Aprotinin and transfusion requirements in orthotopic liver transplantation: a multicentre randomised double-blind study. EMSALT Study Group.  Lancet. 2000;  355 (9212) 1303-1309
    CrossrefPubMedGoogle Scholar
  • 116 Hedner U. Recombinant activated factor VIIa as a universal haemostatic agent.  Blood Coag Fibrinol. 1998;  9 (Suppl 1) 147-152
    PubMedGoogle Scholar
  • 117 Ehrenforth S. Therapeutic potential of recombinant activated factor VII in intensive care medicine.  J Anästh Intensiv. 2001;  3 110-112
    PubMedGoogle Scholar
  • 118 Larocque B J, Gilbert K, Brien W F. A point score system for predicting the likelihood of blood transfusion after hip or knee arthroplasty.  Transfusion. 1997;  37 463-467
    CrossrefPubMedGoogle Scholar
  • 119 Hansen E, Altmeppen J, Taeger K. Autologous haemotherapy in malignant diseases. Clinical anaesthesiology: Blood, blood products and blood saving techniques. Kretschmer V, Blauhut B (eds). 1997 6: 335-350
    Google Scholar
  • 120 Mac Douglas N. The patient's blood is the safest blood.  N Engl J Med. 1987;  316 542-544
    PubMedGoogle Scholar
  • 121 Mempel W, Lehr L. Präoperative Eigenblutspende und -bereitstellung.  Chiurg. 1994;  65 1075-1079
    PubMedGoogle Scholar
  • 122 Bormann von B, Aulich S. Autologe Transfusionsverfahren: Nutzen und Risiko.  Dtsch Ärzteblatt. 1993;  90 2912-2918
    PubMedGoogle Scholar
  • 123 Jaffray B. Predeposit autologous blood transfusion in patients with colorectal cancer: a feasibility study.  Br J Surg. 1992;  79 977
    PubMedGoogle Scholar
  • 124 Hoynck von X, Papendrecht M A, Hop W, Langenhorst B L, Kothe F C, Marquet R L, Jeekel J. Feasibility of a predeposit autologous blood donation program in colorectal cancer patients: Results from a randomized clinical study.  Vox Sang. 1992;  62 102-107
    PubMedGoogle Scholar
  • 125 Harrison S, Steele R JC, Johnson A K. et al . Predeposit autologous blood transfusion in patients with colorectal cancer: a feasibility study.  Br J Surg. 1992;  79 355-357
    PubMedGoogle Scholar
  • 126 Linden J V, Wagner K, Voytovich A E, Sheehan J. Transfusion errors in New York State: an analysis of 10 years' experience.  Transfusion. 2000;  40 1207-1213
    CrossrefPubMedGoogle Scholar
  • 127 Popovsky M A, Whitaker B, Arnold N L. Severe outcomes of allogeneic and autologous blood donation frequency and characterization.  Transfusion. 1995;  35 734-737
    CrossrefPubMedGoogle Scholar
  • 128 Blutmanagement in der Chirurgie. Symposium St. Barbara Hospital Gladbeck
    Google Scholar
  • 129 Kiesewetter H, Jung F, Koscielny J, Pindur G, Wenzel E. Qualitätssicherung bei der Eigenblutentnahme von kritisch Kranken.  Beitr Infusionsther. 1993;  31 202-208
    PubMedGoogle Scholar
  • 130 Heiss M M, Fraunberger P, Delanoff C, Stets R, Allgayer H, Stroehlein M A, Tarabichi A, Faist E, Jauch K W, Schildberg F W. Modulation of immune response by blood transfusion: evidence for a differential effect of allogeneic and autologous blood in colorectal cancer surgery.  Shock. 1997;  8 402-408
    CrossrefPubMedGoogle Scholar
  • 131 Heiss M M, Fasol-Merten K, Allgayer H, Stroehlein M A, Tarabichi A, Wallner S, Eissner H I, Jauch K W, Schildberg F W. Influence of autologous versus allogeneic blood transfusion on natural killer and lymphokine-activated killer cell activities in cancer surgery.  Vox Sang. 1997;  73 237-245
    CrossrefPubMedGoogle Scholar
  • 132 AuBuchon J P, Birkmeyer J D. Controversies in transfusion medicine.  Is autologous blood transfusion worth the cost? Transfusion. 1994;  34 79-83
    PubMedGoogle Scholar
  • 133 Goldfinger D, Haimowitz M. Controversies in transfusion medicine. Is autologous blood transfusion worth the cost?.  Transfusion. 1994;  34 75-78
    CrossrefPubMedGoogle Scholar
  • 134 Etchason J, Petz L, Keeler E. et al . The cost effectiveness of preoperative autologous blood donations.  N Engl J Med. 1995;  332 719-724
    CrossrefPubMedGoogle Scholar
  • 135 Birkmeyer J D, AuBuchon J P, Littenberg B. et al . Cost-effectiveness of preoperative autologous donation in coronary artery bypass grafting.  Ann Thorac Surg. 1994;  57 161-168
    PubMedGoogle Scholar
  • 136 Birkmeyer J D, Goodnough L T, AuBuchon J P, Littenberg B. et al . The cost-effectiveness of preoperative autologous blood donation for total hip and knee replacement.  Transfusion. 1993;  33 544-551
    CrossrefPubMedGoogle Scholar
  • 137 Lane T A. The effect of storage on the metastatic potential of tumor cells collected in autologous blood.  Transfusion. 1989;  29 418-420
    CrossrefPubMedGoogle Scholar
  • 138 Mynster T, Nielsen H J. The impact of storage time of transfused blood on postoperative infectious complications in rectal cancer surgery.  Scand J Gastroenterol. 2000;  35 212-217
    CrossrefPubMedGoogle Scholar
  • 139 Marquet R L, Busch O R, Jeekel J, Heiss M M, Amato A C. Are allogeneic blood transfusions acceptable in elective surgery in colorectal carcinoma?.  Eur J Cancer. 1999;  35 352-360
    CrossrefPubMedGoogle Scholar
  • 140 Edna T H, Bjerkeset T. Association between transfusion of stored blood and infective bacterial complications after resection for colorectal cancer.  Eur J Surg. 1998;  164 449-456
    CrossrefPubMedGoogle Scholar
  • 141 Hoh H, Umpleby H, Cooper A, Taylor I. Recurrence of colorectal cancer and perioperative blood transfusion. Is blood storage time important?.  Dis Colon Rectum. 1990;  33 127-130
    PubMedGoogle Scholar
  • 142 Sibrowski W, Cassens U. Einfluss von Lagerung und Konservierung auf die Qualität von Blutzellen.  Anästhesiol Intensivmed Notfallmed Schmerzther. 1998;  33 673-675
    PubMedGoogle Scholar
  • 143 Blajchman M A. Immunomodulatory effects of allogeneic blood transfusions: clinical manifestations and mechanisms.  Vox Sang. 1998;  74 (Suppl 2) 315-319
    PubMedGoogle Scholar
  • 144 Richtlinien zur Gewinnung von Blut und Blutbestandteilen und zur Anwendung von Blutprodukten Hämotherapie. Neu bearbeitete Fassung. Deutscher Ärzte-Verlag Köln 2000
    Google Scholar
  • 145 Prionen-Forschung und -Diagnostik. Vom BSE-Schnelltest bis zum Nachweis von Prionen im Blut. Dtsch Ärzteblatt 2000 49: B2786-2788
    Google Scholar
  • 146 Turner M L, McClelland D BL. The role of r-HuEPO in surgical transfusion practice.  Erythropoiesis. 1995;  6 107-113
    PubMedGoogle Scholar
  • 147 Henry D H. Recombinant human erythropoietin in the treatment of the anemia associated with solid tumors. Bauer C, Koch KM et al Epo-molecular physiology and clinical applications. NY, Marcel Dekker 1994: 293ff
    Google Scholar
  • 148 Heiss M M, Tarabichi A, Allgayer H, Jauch K W, Mempel W, Schildberg F W, Messmer K. Perisurgical erythropoietin application in anemic patients with colorectal cancer: a double-blind randomized study.  Surgery. 1996;  5 523-527
    PubMedGoogle Scholar
  • 149 Eckardt K U. Erythropoietin: Karriere eines Hormons.  Dtsch Ärzteblatt. 1998;  6 B245-250
    PubMedGoogle Scholar
  • 150 Rationale für den Einsatz von Erythropoetin in der Tumortherapie. Beilage in „Der Onkologe” 2000 6 8
    Google Scholar
  • 151 Erythropoietin in der Tumortherapie. Beilage in „Der Onkologe” 1999 5 2
    Google Scholar
  • 152 Erythropoietin - neue Aspekte für die Tumortherapie. Beilage in „Der Onkologe” 1999 5 6
    Google Scholar
  • 153 Die Bedeutung von Epoetin alfa bei der Behandlung operativer Blutverluste. Expertenmeeting in Wien 7. .4..1995
    Google Scholar
  • 154 Goodnough L T, Skikne B, Brugnara C. Erythropoietin, iron, and erythropoiesis.  Blood. 2000;  96 823-833
    PubMedGoogle Scholar
  • 155 Scigalla P, Franke W, Messinger D. Rationale für die Eigenblutspende in der elektiven Chirurgie mit oder ohne Einsatz von rekombinanten, humanem Erythropoietin in Innovative Aspekte der klinischen Medizin. Springer 1994 3
    Google Scholar
  • 156 Die Rolle von rhErythropoietin im Rahmen fremdblutsparender Methoden. Beilage in „Der Chirurg” 1994 65 4
    Google Scholar
  • 157 Rau B, Schlag P M, Willeke F, Herfarth C, Stephan P, Franke W. Increased autologous blood donation in rectal cancer by recombinant human erythropoietin.  Eur J Cancer. 1998;  34 992-998
    CrossrefPubMedGoogle Scholar
  • 158 Jeekel J. Autologous blood donation and epoetin alfa in cancer surgery.  Semin Hematol. 1996;  33 (2 Suppl 2) 43-46, discussion 47
    PubMedGoogle Scholar
  • 159 Ludwig H, Fritz E. Pathogenese und Therapie der therapie- und tumorbedingten Anämie. Kompendium Internistische Onkologie, Springer 1996: 1118-1127
    Google Scholar
  • 160 Ludwig H, Fritz E, Leitgeb C, Krainer M, Kührer I, Sagaster P, Umek H. Erythropoietin treatment for chronic anemia of selected hematological malignancies and solid tumors.  Ann Oncol. 1993;  4 61-167
    PubMedGoogle Scholar
  • 161 Cazzola M, Mercuriali F, Brugnara C. Use of recombinant erythropoietin outside the setting of uremia.  Blood. 1997;  89 4248-4267
    PubMedGoogle Scholar
  • 162 Levine E A, Laborde C, Hambrick E. et al . Influence of Erythropoietin on Transfusion Requirements in Patients Receiving Preoperative Chemoradiotherapy for Rectal Cancer.  Dis Colon Rectum. 1999;  42 1065-1071
    PubMedGoogle Scholar
  • 163 Glaser G, Millesi W, Wanschitz F, Schüll B, Lang S, Leitha T, Kornek G V. R-HuErythropoietin treatment increases efficacy of neoadjuvant radiochemotherapy and improves cancer free survival of patients with oral squamous cell carcinoma.  Proc Am Soc Clin Oncol. 1999;  18 399a
    PubMedGoogle Scholar
  • 164 Hoeckel M, Schlenger K, Aral B, Mitze M, Schäffer U, Vaupel P. Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix.  Cancer Res. 1996;  56 4509-4515
    PubMedGoogle Scholar
  • 165 Henke M, Guttenberger R. Erythropoietin in Radiation Oncology - A Review.  Oncology. 2000;  58 175-182
    PubMedGoogle Scholar
  • 166 Die Bedeutung erhöhter Hämoglobinspiegel für Tumoroxygenierung, Radiotherapie und Prognose. Beilage in „Der Onkologe” 1998 4 3
    Google Scholar
  • 167 Glimelius B, Linné T, Hoffmann K. et al . Epoetin Beta in the Treatment of Anemia in Patients With Advanced Gastrointestinal Cancer.  J Clin Oncol. 1998;  16 434-440
    PubMedGoogle Scholar
  • 168 Nowrousian M R. Behandlung der tumor- oder chemotherapiebedingten Anämie mit Erythropoietin. Remission 2-99
    Google Scholar
  • 169 Westphal G. et al .Experimental data concerning safety profile of rhEpo in the treatment of cancer patients. Smith JF, Boogaerts MA and Ehmer BRM (eds) rh Erythropoietin in Cancer Supportive Treatment. 1996: 149-158
    Google Scholar
  • 170 Sowade B. et al . The safety of treatment with recombinant humanerythropoietin in clinical use: A review of controlled studies.  Int J Mol Med. 1998;  1 303-314
    PubMedGoogle Scholar
  • 171 Weisbach V, Eckstein R. Eisenhaushalt und präoperative Eigenblutspende.  Infusionsther Transfusionsmed. 1996;  23 161-170
    PubMedGoogle Scholar
  • 172 Habler O, Kleen M, Meßmer K. Künstliche Sauerstoffträger. Alternativen zur Fremdbluttransfusion?.  Zentralbl Chir. 1999;  124 260-270
    PubMedGoogle Scholar

Dr. K. Pfister

Chirurgische Klinik und Poliklinik der Universität Regensburg

Franz-Josef-Strauß-Allee 11

93053 Regensburg

Phone: 0941-9446801

Fax: 0941-9446802

Email: Karin.pfister@Klinik.uni-regensburg.de